We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Akorn, Fera, Perrigo Settle Trade Secrets, Antitrust Suit

Law360, New York (January 30, 2018, 3:13 PM EST) -- Fera Pharmaceuticals LLC and Akorn Inc. have settled a $100 million trade secrets case tied to a supply agreement for eye infection treatments, along with antitrust counterclaims that brought Perrigo Co. PLC into the mix, ending the suit Monday, just weeks before a scheduled trial.

Perrigo attorney Christopher W. Healy of Reed Smith LLP sent a letter to the New York federal court Saturday asking for the Feb. 20 trial date to be canceled given the settlement, which he said they’re still finalizing. Senior U.S. District...
To view the full article, register now.




Case Information

Case Title

FERA Pharmaceuticals, LLC v. Akorn, Inc. et al

Case Number



New York Southern

Nature of Suit

Contract: Other


Louis L. Stanton

Date Filed

October 15, 2012

Law Firms


Government Agencies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.